October 21, 2013

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2013 ACS

Patent Number: WO 2013123277
Title: Preparation of tricyclic indole derivatives useful as endothelial lipase inhibitors
Inventor(s): Connelly, Margery A.; Greco, Michael; Ye, Hong
Patent Assignee(s): Janssen Pharmaceutica, NV, Belg.
Source: U.S. Pat. Appl. Publ., 30pp. CODEN: USXXCO
Language: English

Abstract:
The present invention is directed to tricyclic indole derivs. I [R1 = (CH2)a-Ph, (CH2)b-O-phenyl; a = 1-5; b = 1-4; Ph of group R1 can be optionally substituted with halo, alkyl, alkoxy; R2 = H, OH, OMe, NH2; ring A = 5-7 membered, satd. ring structure selected from II-VII; R3 = H, alkyl, alkyl-OH, etc.; with the provisos], pharmaceutical compns. contg. them and their use in the treatment of disorders and conditionsmodulated by endothelial lipase, for example, cardiovascular disorders.  Over twenty compds. I were prepd.  E.g., a multi-step synthesis of VIII, starting from 2-ethoxy-3-phenethyl-2-(trifluoromethyl)oxirane and 2,3,4,5-tetrahydro-1H-benzo[b]azepine, was described.  Exemplified compds. I were tested in the endothelial lipase assay (data given).

Please note:  Abstracts and Titles for patent records in CAplus are routinely enhanced to better describe the claimed invention.

 View the full-text here.

Recent News

 
    April 17, 2014 | Multi-Year Deal Secures SciFinder
    Access for Prague Consortium Researchers

    April 16, 2014 | New Format Adopted for Taiwanese
    Granted Patent Numbers in CAS Databases and
    INPADOC

    March 26, 2014 | New STN Platform Enhancements
    Available, Increase Efficiency of Search Workflow

                                                                       More News >> 

 Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624                                       
 Email: cas-pr@cas.org